Employees: 912
Size Qianjiang Yongan Pharmaceutical (002365.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $523M, the 3753rd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥12.09 on 6 Nov 2026.
Performance Over six months the shares fell 11.8%, against -15.2% for the median peer and -16.4% for the China market (cap-weighted) — 7th highest of 21 in its peer set.
Growth Revenue grew 26.0% over the last twelve months (peer median +8.3%); the operating margin is 4.1% (peer median 1.2%).
Valuation It trades at 2.7× enterprise value to sales against a peer median of 2.2× (8th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 25% a year for seven years (Req g). Recent delivered growth is -8%, so the hurdle is +32 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 2.4 points below its cost of capital (5.0% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥979M | CN¥779M | CN¥835M | CN¥969M | CN¥1.46B |
| Revenue growth | — | -7% | -14% | -33% | — |
| Gross profit | CN¥207M | CN¥117M | CN¥150M | CN¥236M | CN¥462M |
| EBITDA | CN¥156M | CN¥109M | CN¥152M | CN¥159M | CN¥293M |
| Net income | CN¥53.4M | CN¥22.5M | CN¥61.8M | -CN¥12.3M | CN¥140M |
| Free cash flow | CN¥28.4M | CN¥105M | CN¥23.0M | CN¥124M | CN¥265M |
| Capital expenditure | CN¥118M | CN¥62.3M | CN¥118M | CN¥121M | CN¥149M |
| Total debt | CN¥3.22M | CN¥9.96M | CN¥46.0M | CN¥47.3M | CN¥47.2M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002365.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -7.8% | -14.9% | 4th highest of 21 |
| 6-month return | -11.8% | -15.2% | 7th highest of 21 |
| Distance from 52-week high | -33.2% | -44.7% | 8th highest of 21 |
| Revenue growth (TTM) | +26.0% | +8.3% | 6th highest of 21 |
| Operating margin | 4.1% | 1.2% | 10th highest of 21 |
| EV / Sales | 2.7× | 2.2× | 8th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 24.7% | 21.7% | 5th most demanding of 10 |
| Growth delivered (Del g) | -7.8% | +7.0% | 2nd lowest of 10 |
| Hurdle (Req g minus delivered) | +32.4 pp | +0.7 pp | 2nd most demanding of 10 |
| ROIC minus cost of capital | -2.4 pp | -4.1 pp | 7th highest of 21 |
| EV / EBITDA | 16.9× | 9.7× | 4th most expensive of 8 |
| Net debt / EBITDA | -5.3× | -0.2× | 3rd least indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Qianjiang Yongan Pharmaceutical 002365.SZ | China | $523M | -12% | +26% | 4% | 2.7× | 24.7% | -7.8% |
| Jiangsu Feymer Technology 688350.SS | China | $528M | -14% | -6% | -1% | 3.0× | 30.2% | +4.2% |
| DKS 4461.T | Japan | $530M | -6% | +31% | 15% | 0.9× | 5.3% | +7.0% |
| Gansu Yatai Industrial Developent 000691.SZ | China | $516M | -6% | +29% | 0% | 5.9× | n/a | n/a |
| Suzhou Sunmun Technology 300522.SZ | China | $534M | -15% | -5% | -2% | 5.4× | n/a | n/a |
| Jiangsu Jiangnan High Polymer Fiber 600527.SS | China | $538M | -30% | +2% | 1% | 4.7× | 40.2% | -14.6% |
| Sichuan Meifeng Chemical Industry 000731.SZ | China | $509M | -14% | -13% | -6% | 0.5× | n/a | n/a |
| Shandong Haihua 000822.SZ | China | $509M | -36% | -10% | -33% | 1.3× | n/a | n/a |
| Puyang Huicheng Electronic Material 300481.SZ | China | $540M | -16% | +11% | 9% | 2.1× | n/a | n/a |
| Jiangsu Jinji Industrial 300798.SZ | China | $507M | -33% | +28% | 0% | 2.5× | n/a | n/a |
| Hangzhou Flariant 605566.SS | China | $505M | -23% | +22% | 8% | 2.5× | n/a | n/a |
| Shandong Lubei Chemical 600727.SS | China | $545M | -15% | +6% | 7% | 0.9× | n/a | n/a |
| Great Chinasoft Technology 002453.SZ | China | $497M | -27% | -5% | -54% | 8.2× | n/a | n/a |
| Tidewater Renewables LCFS.TO | Canada | $495M | +97% | +24% | 20% | 2.4× | -3.0% | +126.4% |
| Savita Oil Technologies SOTL.NS | India | $491M | +61% | +26% | 10% | 1.0× | 17.5% | +16.8% |
| Jinneng Science & Technology 603113.SS | China | $559M | -34% | +6% | -4% | 0.5× | n/a | n/a |
| Guangdong Tianan New Material 603725.SS | China | $489M | +9% | -12% | 2% | 1.5× | 21.7% | +29.0% |
| Advanced Nano Products 121600.KS | South Korea | $565M | -23% | +33% | 12% | 5.5× | 28.1% | +18.2% |
| Koppers KOP | United States | $567M | -32% | -5% | 10% | 0.8× | -7.1% | +2.4% |
| Jiangxi Chenguang New Materials 605399.SS | China | $482M | -30% | +15% | -9% | 2.8× | n/a | n/a |
| IOL Chemicals & Pharmaceuticals IOLCP.NS | India | $569M | +87% | +19% | 9% | 2.1× | 29.8% | +3.5% |